Preventive cardiology or cardiometabolic medicine: a new and emerging subspecialty?
作者信息
Wong Nathan D
机构信息
Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California, Irvine, California, USA.
出版信息
Cardiovasc Endocrinol Metab. 2020 May 18;9(3):66-69. doi: 10.1097/XCE.0000000000000206. eCollection 2020 Sep.
Abstract
摘要
相似文献
1
Preventive cardiology or cardiometabolic medicine: a new and emerging subspecialty?预防心脏病学或心脏代谢医学：一个新兴的亚专业？
Cardiovasc Endocrinol Metab. 2020 May 18;9(3):66-69. doi: 10.1097/XCE.0000000000000206. eCollection 2020 Sep.
2
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.预防心脏病学作为心血管医学的一个亚专科：JACC 委员会观点。
J Am Coll Cardiol. 2019 Oct 15;74(15):1926-1942. doi: 10.1016/j.jacc.2019.08.1016.
3
Providing pediatric subspecialty care: A workforce analysis. AAP Committee on Pediatric Workforce Subcommittee on Subspecialty Workforce.提供儿科亚专业护理：劳动力分析。美国儿科学会儿科劳动力委员会亚专业劳动力小组委员会。
Pediatrics. 2000 Dec;106(6):1325-33. doi: 10.1542/peds.106.6.1325.
4
Paediatric cardiology: a future model or a shrinking subspecialty.
Cardiol Young. 2004 Aug;14(4):460-2. doi: 10.1017/S1047951104004202.
5
Cardiology fellowship subspecialty training opportunities in Canada.
Hosp Med. 1999 Aug;60(8):588-91. doi: 10.12968/hosp.1999.60.8.1741.
6
Congenital heart disease in adults. A new cardiovascular subspecialty.成人先天性心脏病。一个新的心血管亚专业。
Circulation. 1991 Nov;84(5):1881-90. doi: 10.1161/01.cir.84.5.1881.
7
The time has come for vascular medicine? Angiology: a subspecialty of internal medicine and dermatology in Switzerland.血管医学的时代已经到来？血管学：瑞士内科和皮肤科的一个亚专业。
Int Angiol. 1991 Jul-Sep;10(3):162-6.
8
Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future.作为一项专门临床服务的预防心脏病学：过去、现在及（辉煌的）未来。
Am J Prev Cardiol. 2020 Mar;1:100011. doi: 10.1016/j.ajpc.2020.100011. Epub 2020 May 12.
9
Heart failure training: a call for an integrative, patient-focused approach to an emerging cardiology subspecialty.心力衰竭培训：呼吁采用以患者为中心的综合方法来应对新兴的心脏病学亚专业。
J Am Coll Cardiol. 2004 Oct 6;44(7):1361-2. doi: 10.1016/j.jacc.2004.06.055.
10
Publications in subspecialty journals on end-of-life ethics.专业期刊上关于临终伦理的出版物。
Arch Intern Med. 1997 Mar 24;157(6):685-90.
引用本文的文献
1
The future of cardiovascular and metabolic medical practice: evidence-based winds of change.心血管与代谢医学实践的未来：循证变革之风
Cardiovasc Endocrinol Metab. 2020 Jul 16;9(3):64-65. doi: 10.1097/XCE.0000000000000226. eCollection 2020 Sep.
本文引用的文献
1
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新：来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
2
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.预防心脏病学作为心血管医学的一个亚专科：JACC 委员会观点。
J Am Coll Cardiol. 2019 Oct 15;74(15):1926-1942. doi: 10.1016/j.jacc.2019.08.1016.
3
Control of Cardiovascular Risk Factors Among US Adults With Type 2 Diabetes With and Without Cardiovascular Disease.美国 2 型糖尿病合并或不合并心血管疾病患者心血管风险因素的控制。
Am J Cardiol. 2019 Aug 15;124(4):522-527. doi: 10.1016/j.amjcard.2019.05.035. Epub 2019 May 28.
4
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019 ACC/AHA 心血管疾病一级预防指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. Epub 2019 Mar 17.
5
Cardiometabolic Medicine: A Call for a New Subspeciality Training Track in Internal Medicine.心脏代谢医学：呼吁在内科设立新的亚专业培训方向。
Am J Med. 2019 Jul;132(7):788-790. doi: 10.1016/j.amjmed.2019.02.027. Epub 2019 Mar 12.
6
Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.美国心脏病学会/美国心脏协会他汀类药物适宜性分组、他汀类药物使用情况以及美国成年人低密度脂蛋白胆固醇控制的流行率，使用的是 2011-2012 年全国健康和营养调查。
J Clin Lipidol. 2016 Sep-Oct;10(5):1109-18. doi: 10.1016/j.jacl.2016.06.011. Epub 2016 Jun 29.
7
Legacy of the framingham heart study: rationale, design, initial findings, and implications.弗雷明汉心脏研究的遗产：原理、设计、初步发现及影响。
Glob Heart. 2013 Mar;8(1):3-9. doi: 10.1016/j.gheart.2012.12.001. Epub 2013 Mar 15.
8
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV：欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
9
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.美国心脏协会/美国心脏病学会基金会关于冠状动脉及其他动脉粥样硬化性血管疾病患者二级预防和风险降低治疗的指南：2011年更新版
Circulation. 2011 Nov 29;124(22):2458-73. doi: 10.1161/CIR.0b013e318235eb4d. Epub 2011 Nov 3.
10
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study.冠心病发病的危险因素——六年随访经验。弗明汉姆研究。
Ann Intern Med. 1961 Jul;55:33-50. doi: 10.7326/0003-4819-55-1-33.
Zotero 插件